pirfenidone has been researched along with plerixafor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Oupicky, D; Sun, M; Ullah, A; Wang, K; Wu, P | 1 |
1 other study(ies) available for pirfenidone and plerixafor
Article | Year |
---|---|
CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation.
Topics: Animals; Apoptosis; Benzylamines; Cell Line; Cell Line, Tumor; Cell Survival; Cyclams; Drug Delivery Systems; Endocytosis; Hepatic Stellate Cells; Heterocyclic Compounds; Humans; Liposomes; Liver Cirrhosis; Mice; p38 Mitogen-Activated Protein Kinases; Pyridones; Rats; Receptors, CXCR4; Signal Transduction; Tissue Distribution; Transforming Growth Factor beta | 2019 |